DIPS (Dystonia Image-based Programming of Stimulation: a prospective, randomized, double-blind crossover trial)

被引:3
|
作者
Lange, Florian [1 ,2 ]
Roothans, Jonas [1 ,2 ]
Wichmann, Tim [1 ,2 ]
Gelbrich, Goetz [3 ,4 ]
Roeser, Christoph [4 ]
Volkmann, Jens [1 ,2 ]
Reich, Martin [1 ,2 ]
机构
[1] Univ Hosp, Dept Neurol, Josef Schneider Str 11, D-97080 Wurzburg, Germany
[2] Julius Maximilian Univ, Josef Schneider Str 11, D-97080 Wurzburg, Germany
[3] Univ Wurzburg, Inst Clin Epidemiol & Biometry ICE B, Josef Schneider Str 2, D-97080 Wurzburg, Germany
[4] Univ Wurzburg, Clin Trial Ctr CTC, Josef Schneider Str 2, D-97080 Wurzburg, Germany
来源
NEUROLOGICAL RESEARCH AND PRACTICE | 2021年 / 3卷 / 01期
关键词
Deep brain stimulation; Dystonia; Imaging-guided DBS programming; DEEP-BRAIN-STIMULATION; CERVICAL DYSTONIA; IMPACT;
D O I
10.1186/s42466-021-00165-6
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
IntroductionDeep brain stimulation of the internal globus pallidus is an effective treatment for dystonia. However, there is a large variability in clinical outcome with up to 25% non-responders even in highly selected primary dystonia patients. In a large cohort of patients we recently demonstrated that the variable clinical outcomes of pallidal DBS for dystonia may result to a large degree by the exact location and stimulation volume within the pallidal region. Here we test a novel approach of programing based on these insights: we first defined probabilistic maps of anti-dystonic effects by aggregating individual electrode locations and volumes of tissue activated of > 80 patients collected in a multicentre effort. We subsequently modified the algorithms to be able to test all possible stimulation settings of de novo patients in silico based on the expected clinical outcome and thus potentially predict the best possible stimulation parameters for the individual patients.MethodsWithin the framework of a BMBF-funded study, this concept of a computer-based prediction of optimal stimulation parameters for patients with dystonia will be tested in a randomized, controlled crossover study. The main parameter for clinical efficacy and primary endpoint is based on the blinded physician rating of dystonia severity reflected by Clinical Dystonia Rating Scales for both interventions (best clinical settings and model predicted settings) after 4 weeks of continuous stimulation. The primary endpoint is defined as "successful treatment with model predicted settings" (yes or no). The value is "yes" if the motor symptoms with model predicted settings are equal or better (tolerance 5% of absolute difference in percentages) to clinical settings. Secondary endpoints will include measures of quality of life, calculated energy consumption of the neurostimulation system and physician time for programming.PerspectiveWe envision, that computer-guided deep brain stimulation programming in silico might provide optimal stimulation settings for patients with dystonia without the burden of months of programming sessions. The study protocol is designed to evaluate which programming method is more effective in controlling motor symptom severity and improving quality of life in dystonia (best clinical settings and model predicted settings).Trial registration Registered with ClinicalTrials.gov on Oct 27, 2021 (NCT05097001).
引用
收藏
页数:6
相关论文
共 50 条
  • [21] DOUBLE-BLIND TRIAL OF BOTULINUM TOXIN FOR TREATMENT OF FOCAL HAND DYSTONIA
    COLE, R
    HALLETT, M
    COHEN, LG
    MOVEMENT DISORDERS, 1995, 10 (04) : 466 - 471
  • [22] A randomized, double-blind study of repeated incobotulinumtoxinA (Xeomin®) in cervical dystonia
    Virgilio Gerald H. Evidente
    Hubert H. Fernandez
    Mark S. LeDoux
    Allison Brashear
    Susanne Grafe
    Angelika Hanschmann
    Cynthia L. Comella
    Journal of Neural Transmission, 2013, 120 : 1699 - 1707
  • [23] A prospective, randomized, double-blind, controlled clinical trial of enteral immunonutrition in the critically ill
    Atkinson, S
    Sieffert, E
    Bihari, D
    CRITICAL CARE MEDICINE, 1998, 26 (07) : 1164 - 1172
  • [24] Directional Deep Brain Stimulation for Parkinson's Disease: Results of an International Crossover Study With Randomized, Double-Blind Primary Endpoint
    Schnitzler, Alfons
    Mir, Pablo
    Brodsky, Matthew A.
    Verhagen, Leonard
    Groppa, Sergiu
    Alvarez, Ramiro
    Evans, Andrew
    Blazquez, Marta
    Nagel, Sean
    Pilitsis, Julie G.
    Poetter-Nerger, Monika
    Tse, Winona
    Almeida, Leonardo
    Tomycz, Nestor
    Jimenez-Shahed, Joohi
    Libionka, Witold
    Carrillo, Fatima
    Hartmann, Christian J.
    Groiss, Stefan Jun
    Glaser, Martin
    Defresne, Florence
    Karst, Edward
    Cheeran, Binith
    Vesper, Jan
    NEUROMODULATION, 2021,
  • [25] Randomised, double-blind, placebo-controlled trial to assess the potential of cannabinoid receptor stimulation in the treatment of dystonia
    Fox, SH
    Kellett, M
    Moore, AP
    Crossman, AR
    Brotchie, JM
    MOVEMENT DISORDERS, 2002, 17 (01) : 145 - 149
  • [26] Long versus short pulse width subcallosal cingulate stimulation for treatment-resistant depression: a randomised, double-blind, crossover trial
    Ramasubbu, Rajamannar
    Clark, Darren L.
    Golding, Sandra
    Dobson, Keith S.
    Mackie, Aaron
    Haffenden, Angela
    Kiss, Zelma H. T.
    LANCET PSYCHIATRY, 2020, 7 (01): : 29 - 40
  • [27] Effect of arabinogalactan on the gut microbiome: A randomized, double-blind, placebo-controlled, crossover trial in healthy adults
    Chen, Oliver
    Sudakaran, Sailendharan
    Blonquist, Traci
    Mah, Eunice
    Durkee, Shane
    Bellamine, Aouatef
    NUTRITION, 2021, 90
  • [28] An Exploratory, Randomized, Double-Blind Clinical Trial of Dipraglurant for Blepharospasm
    Kilic-Berkmen, Gamze
    Kim, Hodam
    Chen, Dongdong
    Yeo, Cameron I.
    Dinasarapu, Ashok R.
    Scorr, Laura M.
    Yeo, Woon-Hong
    Peterson, David A.
    Williams, Hilde
    Ruby, April
    Mills, Roger
    Jinnah, H. A.
    MOVEMENT DISORDERS, 2024, 39 (04) : 738 - 745
  • [29] Motor cortex stimulation for chronic neuropathic pain: results of a double-blind randomized study
    Hamani, Clement
    Fonoff, Erich T.
    Parravano, Daniella C.
    Silva, Valquiria A.
    Galhardoni, Ricardo
    Monaco, Bernardo A.
    Navarro, Jessie
    Yeng, Lin T.
    Teixeira, Manoel J.
    de Andrade, Daniel Ciampi
    BRAIN, 2021, 144 : 2994 - 3004
  • [30] A Prospective, Randomized, Double-Blind Study Comparing the Efficacy and Safety of Type A Botulinum Toxins Botox and Prosigne in the Treatment of Cervical Dystonia
    Aparecida Barasnevicius Quagliato, Elizabeth Maria
    Carelli, Edmur Franco
    Viana, Maura Aparecida
    CLINICAL NEUROPHARMACOLOGY, 2010, 33 (01) : 22 - 26